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Abstract
OBJECTIVE: To investigate metabolic signatures in
plasma of cancer patients with abnormal Savda us-
ing plasma-free amino acid profiles, and to evalu-
ate the diagnostic potential of these profiles for the
detection and explanation of the mechanisms of
different symptoms in traditional Uyghur medicine.
METHODS: Plasma samples from cancer patients
with abnormal Savda (n=85) or non-abnormal Sav-
da (n=105) and a healthy control group (n=65)
were analyzed using high-performance liquid chro-
matography (HPLC). Orthogonal projection to la-
tent structures with discriminant analysis was used
for the classification and prediction of abnormal
Savda, and spectral profiles were subjected to Stu-
dent's t-tests to assess statistical significance.
RESULTS: Compared with the healthy group, the
levels of aspartic acid, glutamate, glycine, histidine,
arginine, threonine, alanine, proline, methionine,
isoleucine, leucine and phenylalanine decreased
significantly in plasma of cancer patients with ab-
normal Savda (all P<0.05). Serine, cystine, tyrosine,
valine and lysine levels showed no significant differ-
ences (all P>0.05). Compared with non-abnormal
Savda syndrome patients, abnormal Savda syn-
drome patients showed high concentrations of glu-
tamate, serine, valine, isoleucine, leucine and phe-
nylalanine (all P<0.05). The remaining plasma ami-
no acids showed no significant differences (all P>
0.05).
CONCLUSION: Plasma-free amino acid profiling
has the potential to assist in understanding and de-
termining abnormal Savda. A HPLC-based metabo-
nomic platform could be a powerful tool for the
classification of symptoms in traditional medicine.
© 2014 JTCM. All rights reserved.
Key words: Amino acids; Medicine, Uyghur tradi-
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INTRODUCTION
Disease treatment in traditional Uyghur medicine is
characterized by abnormal body fluid types.1,2 Accord-
ing to the body fluid theory, abnormal Savda is a spe-
cial state and symptom. As a pathological product, it
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can increase the incidence of complex and intractable
diseases like cancer.3-6 A vast quantity of clinical data
suggests that 72% of cancer patients with abnormal
Savda have other diseases including diabetes and hyper-
tension, and the number of asthma patients with ab-
normal Savda is far higher than the number of patients
with the three other abnormal body fluids, these being
abnormal Belghem, abnormal Sapra and abnormal
Kan.4 This perhaps suggests that abnormal Savda is
closely related to complex disease occurrences and de-
velopment.
Cancer is a typically complex disease. Early and ul-
tra-early detection is suggested for improving the sur-
vival rate of cancer patients. Finding metabolic mark-
ers based on metabonomics for cancer and other com-
plex diseases and early classification diagnosis and treat-
ment will be important in future research.
Metabonomics is a new method for studying dynamic
changes in endogenous metabolites in biosystems. This
process applies chemical analysis techniques combined
with chemometric methods using various advanced
techniques such as nuclear magnetic resonance
(NMR), high-performance liquid chromatography
(HPLC)/mass spectrometry to detect and measure low
molecular weight metabolites in human body fluids
and tissues.7,8 We hypothesized that the occurrence and
development processes of abnormal Savda result from
a metabolic abnormality, and that metabonomics will
help provide information on the concept of different
body fluid syndromes.
In our previous study, we used metabonomic analysis
to examine plasma samples from cancer patients with
abnormal Savda and non-abnormal Savda by NMR.
The results indicated that there were differences in
some kinds of metabolites in patients with different
syndromes, including amino acids.9-12 However, the de-
gree of variation of the amino acid content was un-
clear. Protein synthesis and normal cell growth require
amino acids. Understanding whole-body amino acid
metabolism may help explain the biological basis of ab-
normal Savda.
In this study, we used HPLC to determine plasma-free
amino acid profiles of healthy participants, patients
with abnormal Savda and patients with non-abnormal
Savda. We also evaluated the possibility of using this
information for the detection of, and to explain the
mechanisms for, the different symptoms treated with
traditional Uyghur medicine.
MATERIALS ANDMETHODS
Chemicals and reagents
Amino acid standards were purchased from Waters
(Milford, MA, USA). These were: aspartic acid (Asp),
glutamate (Glu), serine (Ser), glycine (Gly), histidine
(His), arginine (Arg), threonine (Thr), alanine (Ala),
proline (Pro), cystine (Cys), tyrosine (Tyr), methio-
nine (Met), valine (Val), isoleucine (Ile), leucine (Leu),
lysine (Lys) and phenylalanine (Phe). An AccQ-Fluor
reagent kit was also obtained from Waters. Acetonitrile
and methanol (HPLC grade) were purchased from Sig-
ma-Aldrich (St. Louis, MO, USA). Sulfuric acid, meth-
anol and n-hexane were analytical grade and were pur-
chased from Tianjin Chemical Reagent Factory (Tian-
jin, China). The water used in the study was ultra-pure
and was produced using a Milli-Q system (Millipore
Corp., Boston, MA, USA).
Sample collection and preparation
Sixty-five healthy volunteers who were confirmed by
medical examination and 190 cancer patients from the
Fourth Affiliated Hospital of Xinjiang Medical Univer-
sity using the staging system of the American Joint
Committee on Cancer were enrolled in the study. Ex-
clusion criteria included individuals with cardiovascu-
lar diseases, hepatic diseases, renal diseases or inflamma-
tory diseases. Pregnant women were also excluded.
Cancer diagnosis was established in patients immediate-
ly prior to the commencement of the study and there-
fore no treatment had yet been administered. Diagno-
sis of abnormal Savda syndrome and non-abnormal
Savda syndrome was made based on physical examina-
tion, according to the symptoms and signs described in
traditional Uyghur medicine,2-4 and confirmed by three
experienced physicians.
In Uyghur medicine, the main clinical manifestations
of abnormal Savda are a fine and slow pulse, blue and
deep orbit, bleak face, bitter taste, gray or black tongue
fur, rough skin, low body temperature, less frequency
of urination (but more volume), insomnia and dreams
and nightmares. The other cancer patients with non-
abnormal Savda syndrome were diagnosed according
to what is written in traditional Uyghur medicine.
There were 85 cases in the abnormal Savda syndrome
group and 105 cases in the non-abnormal Savda syn-
drome group. The average age of participants was (50±
10) years.
Blood samples were collected from participants before
breakfast. Plasma was obtained by centrifugation of
blood samples at 3500 ×g for 10 min, and was immedi-
ately stored at﹣80℃ until used for HPLC.
Samples were allowed to thaw prior to analysis. A stan-
dard sample was prepared by mixing 200 μL plasma
with 400 μL acetonitrile. The mixture was shaken vig-
orously for 30 s and then centrifuged at 12000 ×g for
15 min at 4℃. The supernatant was dried under nitro-
gen at 40℃ . Water was then added (200 μL) and the
sample shaken vigorously for 30 s and filtered using a
micropore filter membrane. A 10-μL filtration sample
was added to 70 μL of borate buffer and 15 μL AQC
reagent and placed in a 55℃ water bath for 10 min be-
fore chromatographic analysis.
The study protocol was approved by the Ethics Com-
mittee of Xinjiang Medical University. All participants
gave written informed consent to participate in the
study.
Apparatus and operation conditions
A Waters e2695 series HPLC system (Milford, MA,
USA) with a 2475 fluorescence detector was used for
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analysis. Chromatographic separation was performed on
an Inertsil ODS-SP (C18, 5 μm particle size, 4.6 mm×
250 mm; Shimadzu, Kyoto, Japan) maintained at 35℃
with a flow rate of 1.0 mL/min. The excitation wave-
length was 235 nm and the emission wavelength was
395 nm. Mobile phase A consisted of methanol-aceto-
nitrile-water at 1∶3∶1 (v/v), and B was acetate buffer
salt. Using a gradient elution of 100% B at 0-5 min;
98% B at 5-6 min; 94% B at 6-15 min; 91% B at
15-19 min; 79% B at 19-32 min; 55% B at 32-34 min;
45% B at 34-38 min; 0% B at 38-45 min. The injec-
tion volume was 5 μL.
Data analysis
After the chromatographic peak area was normalized,
pattern recognition analysis was carried out on data
sets using SIMCA-P+ software (Version 11.0, Umetrics
Inc., Umea, Sweden). A supervised multivariate data
analysis tool called the orthogonal projection to latent
structures with discriminant analysis (OPLS-DA) was
used, with unit-variance scaling to classify the abnor-
mal Savda syndrome cancer group, the non-abnormal
Savda syndrome cancer group and the healthy group.
This was constructed using amino acid concentrations
in plasma as the X matrix and class information identi-
fier for the different groups as the Y variables. In the
current study, R2X and Q2 were used to describe the
quality of the OPLS-DA model. Total explained varia-
tion for the X matrix is R2X, and predictability of the
model is Q2. All amino acid concentrations are ex-
pressed as mean±standard deviation ( xˉ ± s). Student's
t-tests was performed by SPSS (Version 16.0, Chicago,
IL, USA) software to analyze alterations in amino acid
levels among the different groups. A P-value <0.05 was
considered statistically significant.
RESULTS
Typical HPLC chromatography
Results from HPLC chromatography showed that 17
amino acids were separated effectively in 30 min, the
peaks of interest were well separated, and there was no
interference from other amino acids and endogenous
compounds in the plasma (Figure 1).
OPLS-DA analysis
R2X and Q2 were 0.43 and 0.42, respectively. The value
of Q2 showed encouraging prediction ability for this
OPLS-DA model (Figure 2). The results indicated that
the OPLS-DA model had good capability for the classi-
fication of the different symptoms of cancer patients.
Plasma-free amino acid profiling has great potential to
improve the screening and diagnosis of different symp-
toms of cancer and to help with understanding abnor-
mal Savda in traditional Uyghur medicine.
Plasma-free amino acid profiles
Compared with the healthy group, the levels of Asp,
Glu, Gly, His, Arg, Thr, Ala, Pro, Met, Ile, Leu and
Phe decreased significantly in plasma of cancer patients
with abnormal Savda (all P<0.05), but Ser, Cys, Tyr,
Val and Lys levels showed no significant differences (all
P>0.05). Compared with non-abnormal Savda syn-
drome patients, abnormal Savda syndrome patients
had high concentration of Glu, Ser, Val, Ile, Leu and
Phe (all P<0.05) but the other plasma amino acids
showed no significant differences (all P>0.05; Table 1).
DISCUSSION
The body fluid (Hilit) theory of traditional Uyghur
medicine considers that body fluid produced in the liv-
er by various nutrients provides energy for the whole
organism.1,4 According to this theory, the body fluid in-
cludes Savda, Belghem, Sapra and Kan, and abnormal
changes in body fluids are the basis of diseases, which
is called abnormal Hilit.1,2 Based on the symptoms, ab-
normal Hilit is divided into abnormal Savda, abnormal
Belghem, abnormal Sapra and abnormal Kan. Abnor-
mal Savda is a special syndrome and is considered as
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Figure 1 Typical HPLC chromatography profiles of plasma-free amino acids
1: aspartic acid; 2: glutamate; 3: serine; 4: glycine; 5: histidine; 6: arginine; 7: threonine; 8: alanine; 9: proline; 10: cystine; 11: tyro-
sine; 12: valine; 13: methionine; 14: isoleucine; 15: leucine; 16: lysine; 17: phenylalanine. HPLC: high-performance liquid chroma-
tography.
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one of the origins of many complex diseases such as
cancer, diabetes, hypertension and asthma.3-5
Amino acids are an important class of substances in the
activities of life with a wide range of biological func-
tions: the composition of proteins, involved in energy
metabolism and precursors of nitrogen-containing
Amino acid
Asp
Glu
Ser
Gly
His
Arg
Thr
Ala
Pro
Cys
Tyr
Val
Met
Iso
Leu
Lys
Phe
Healthy group
0.037±0.033
0.310±0.279
0.238±0.497
0.257±0.165
0.119±0.089
0.085±0.045
0.183±0.186
0.797±0.961
0.085±0.063
0.029±0.018
0.059±0.051
0.207±0.142
0.110±0.183
0.232±0.168
0.180±0.155
0.076±0.052
0.107±0.066
Abnormal Savda
0.006±0.006
0.075±0.048
0.162±0.162
0.170±0.118
0.074±0.036
0.066±0.038
0.088±0.087
0.237±0.250
0.053±0.053
0.027±0.056
0.077±0.098
0.225±0.217
0.025±0.012
0.130±0.082
0.131±0.085
0.077±0.071
0.068±0.036
Non-abnormal Savda
0.006±0.004
0.061±0.037
0.120±0.136
0.150±0.099
0.082±0.097
0.074±0.040
0.074±0.086
0.240±0.292
0.057±0.040
0.018±0.041
0.068±0.087
0.173±0.092
0.028±0.033
0.103±0.066
0.104±0.067
0.070±0.058
0.059±0.029
P1 value
0.000
0.000
0.092
0.000
0.000
0.001
0.000
0.000
0.000
0.449
0.095
0.287
0.000
0.000
0.007
0.458
0.000
P2 value
0.329
0.009
0.025
0.100
0.234
0.068
0.189
0.464
0.384
0.113
0.311
0.024
0.243
0.007
0.008
0.172
0.015
Table 1 Plasma-free amino acid profiles of cancer patients with abnormal Savda or non-abnormal Savda and healthy participants
(mmol/L, xˉ ±s)
Notes: P1: cancer patients with abnormal Savda compared with healthy participants; P2: cancer patients with abnormal Savda compared
with cancer patients with non-abnormal Savda. Asp: aspartic acid; Glu: glutamate; Ser: serine; Gly: glycine; His: histidine; Arg: arginine;
Thr: threonine; Ala: alanine; Pro: proline; Cys: cystine; Tyr: tyrosine; Met: methionine; Val: valine; Ile: isoleucine; Leu: leucine; Lys: lysine;
Phe: phenylalanine.
3
2
1
0
﹣1
﹣2
﹣3
﹣4
﹣10
﹣5
05
0 50
100
150
200
250
3
2
1
0
﹣1
﹣2
﹣3
﹣4
﹣10 ﹣5
5
0 0 50 100 150 200 250
t[1]P
M6
.t[2
]0
NUM
t[1]P
M6.t[2]0
NUM
Figure 2 Scatter plots of OPLS-DA analysis of plasma amino acids■: healthy controls; ●: cancer patients with abnormal Savda; ◆: and cancer patients with non-abnormal Savda. OPLS-DA: or-
thogonal projection to latent structures with discriminant analysis.
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compounds such as neurotransmitters, nucleic acids
and coenzymes. A variety of pathological conditions
can lead to changes in amino acid metabolism. There-
fore, studying the metabolism of amino acids in the
body under physiological and pathological conditions
contributes to the understanding of the pathological
mechanisms of various diseases, as well as diagnosis
and treatment.
Metabolism in cancer cells is significantly altered com-
pared with normal cells, and these changes are also re-
flected in the plasma amino acid profiles. It has been re-
ported that plasma amino acid profiles can be used to
discriminate between patients with cancer and healthy
controls.13,14 Detecting amino acid profiles in plasma
could potentially be useful for the diagnosis of differ-
ent cancers.
To better understand amino acid metabolism differenc-
es in cancer patients with abnormal Savda, we analyzed
plasma-free amino acid concentrations using HPLC.
We performed plasma amino acid profiling to identify
marker metabolites and to assess whether these marker
metabolites could be used for abnormal Savda detec-
tion in patients with complex diseases. The results
showed that the model used identified patients with ab-
normal Savda, suggesting that plasma amino acid pro-
filing may be useful for the diagnosis of different syn-
dromes in traditional Uyghur medicine.
Savda is produced in the liver by various nutrients ac-
cording to Uyghur medicine.1,4 Amino acids are a neces-
sary nutritional resource, but variations in endogenous
concentrations correlate with diseases.15,16 Therefore,
plasma amino acids are the most suitable candidates
for identifying abnormal Savda as they play essential
physiological roles both as basic metabolites and meta-
bolic regulators.
Tumor tissue continues to uptake amino acids for pro-
tein synthesis and cell proliferation, and plasma-free
amino acids are the major uptake source. Metabolism
of specific amino acids is known to be associated with
specific organs, such as muscles, the liver or kidneys.
Changes in amino acid levels are affected by their me-
tabolism in, and excretion from, multiple organs of the
body, and amino acids are frequently identified com-
pounds among whole metabolites in the blood in rela-
tion to abnormal Savda.
With the rapid growth of a tumor, the tumor and the
body compete for nutrients, especially amino acids,
which inevitably lead to amino acid metabolism disor-
ders. In this study, we found that the amino acid me-
tabolism of patients with abnormal Savda was signifi-
cant different not only to the metabolism of healthy
volunteers but also with non-abnormal Savda patients;
a finding which lends support to the body fluid theory.
It has been reported that patients with several different
types of cancers have low levels of plasma
branched-chain amino acids (BCAA),17-19 including
Val, Leu, and Ile. The results of the current study are
consistent with these reports. It is also of interest there
were different BCAA concentrations observed in plas-
ma of patients with different symptoms.
In this study, cancer patients with abnormal Savda had
higher plasma BCAA levels than non-abnormal Savda
patients. Liver and muscle are important tissues for
amino acid metabolism, so these results may be sugges-
tive of increased protein degradation in skeletal muscle
of abnormal Savda patients being higher than that of
non-abnormal Savda patients.
BCAA are central in the maintenance of skeletal mus-
cle protein metabolism. Traditional Uyghur medicine
considered that patients with abnormal Savda suffer
weight loss and energy metabolism disorders.3,4,9,10 It is
therefore important to examine BCAA metabolism in
the abnormal Savda state, where muscle wasting is
prominent. Skeletal muscle wasting indicates that over-
all protein catabolism is greater than anabolism in can-
cer patients.20 Our previous study indicated that pa-
tients with abnormal Savda showed greater muscle
wasting than non-abnormal Savda patients.21 BCAA
are also thought to affect glucose metabolism.22 Cancer
patients experiencing weight loss showed increased
rates of gluconeogenesis.23 It is therefore possible that
patients with abnormal Savda might have higher gluco-
neogenesis rates than non-abnormal Savda patients.
BCAA are not only a constituent of protein, but also a
source of Glu. It was observed in the current study that
abnormal Savda patients had higher concentrations of
Glu in plasma than non-abnormal Savda patients. Glu
is an amino acid similar to glutamine. In the blood,
Glu is present at a level approximately 25% of that of
glutamine. Glutamine is a key substrate in many syn-
thetic and metabolic processes, such as the breakdown
of skeletal muscle protein,24 and is also a source of al-
pha-ketoglutarate, which plays an anaplerotic role in
the tricarboxylic acid cycle as citrate and malate.25
Ser is a non-essential amino acid. It plays a role in the
metabolism of fats and fatty acids and muscle growth,
and also in the synthesis of the cell membrane, muscle
tissue and the sheath of nerve cells. It is possible that
plasma Ser concentrations of patients with abnormal
Savda may be related somehow with the degradation of
muscle tissue.
According to the body fluid theory, body fluids are de-
rived from the liver. The liver is the main organ in-
volved in protein and amino acid metabolism, and af-
fects protein metabolism by the formation of plasma
proteins, amino acid interconversion, deamination of
amino acids, and urea synthesis. Amino acid abnormal-
ities are common even in patients who have liver cir-
rhosis. For that reason, amino acid metabolic abnor-
malities in the liver become more severe with abnormal
Savda. Phe is important for assessing liver metabolism
and the severity of liver dysfunction.26 High Phe con-
centrations in plasma of abnormal Savda patients may
be related with liver dysfunction.
Plasma is an essential body fluid which contains all
kinds of information about the pathological changes of
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organs and tissues, including information about the
mechanisms of different symptoms like abnormal Sav-
da. Therefore, correlation-based network analysis of
plasma amino acids may help to uncover specific patho-
logical states and aid in establishing strategies for the
early detection of abnormal Savda.
In this study, we examined amino acid metabolism of
cancer patients with different traditional Uyghur medi-
cine symptoms using HPLC analysis. We found that
the amino acid balance in cancer patients with abnor-
mal Savda was significantly different not only to that
of healthy individuals but also cancer patients with
non-abnormal Savda. The results suggest that amino
acid profiling may detect latent variances and may be
able to define chemometric models for the prediction
of abnormal Savda. The HPLC technique described in
this study may have great potential to assist in the un-
derstanding of the substance basis of traditional medi-
cine theory.
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